Form 8-K - Current report:
SEC Accession No. 0001193125-25-058979
Filing Date
2025-03-20
Accepted
2025-03-20 16:08:01
Documents
15
Period of Report
2025-03-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d788212d8k.htm   iXBRL 8-K 34717
2 EX-10.1 d788212dex101.htm EX-10.1 81430
6 GRAPHIC g788212dsp001.jpg GRAPHIC 8244
  Complete submission text file 0001193125-25-058979.txt   270995

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dyn-20250317.xsd EX-101.SCH 2848
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyn-20250317_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyn-20250317_pre.xml EX-101.PRE 10812
17 EXTRACTED XBRL INSTANCE DOCUMENT d788212d8k_htm.xml XML 3497
Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

EIN.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39509 | Film No.: 25756498
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)